Gerontologists who study the science of aging proposed that targeting aging-related pathologies can be a new strategy to fight the pandemic and the health and economic benefits will outlive COVID-19.

Scientists from Washington University School of Medicine in St. Louis identify a nicotinamide mononucleotide (NMN)-specific transporter, Slc12a8, in mice.

Scientists from China provide evidence: nicotinamide mononucleotide (NMN) treatment restores bone loss from aluminum consumption in rats. 

Very pure Nicotinamide Mononucleotide (NMN) is available as a supplement but scientists are still learning about the way in which it is absorbed utilized and excreted by our bodies.

Scientists from Keio University School of Medicine in Japan publish first study evaluating safety of nicotinamide mononucleotide (NMN) administration in humans, showing no adverse health concerns.